Navigation Links
Johnson City Medical Center Begins Offering Einstein Bros. Menu Items at Second On Campus Location
Date:12/27/2007

Location Becomes 30th License Location to Begin Offering Menu Items in 2007

JOHNSON CITY, Tenn., Dec. 27 /PRNewswire-FirstCall/ -- Patients, employees and visitors of Johnson City Medical Center now have an even more convenient way to get their favorite craveable food and Darn Good Coffee(R), as the facility began serving Einstein Bros.(R) Bagels menu items in a second location at the medical center recently.

The second location serving Einstein Bros. near the front lobby of Johnson City Medical Center is the 30th license location to begin offering Einstein Bros. products in 2007. Guests can now choose from a selection of Einstein Bros.' eclectic sandwiches made with high quality ingredients, crisp, fresh salads and Darn Good Coffee(R).

These items and much more will be served from the medical center's second complete Einstein Bros. license restaurant when it opens next near, which is tentatively scheduled to occur in March. The first Einstein Bros. license restaurant at the Medical Center opened more than a year ago is still serving guests in the Center for Cardiovascular Health. It was also the first Einstein Bros restaurant to open in the region.

"I'm pleased that Johnson City Medical Center has elected to open another Einstein Bros. restaurant on campus," said Paul Carolan, senior vice president of franchising and licensing for Einstein Noah Restaurant Group (Nasdaq: BAGL). "The neighborhood friendly atmosphere and signature menu offerings have proven to be a great fit for Johnson City Medical Center and the health care environment."

There are now 13 license locations at health care facilities that are currently serving Einstein Bros. menu items.

"Einstein Noah Restaurant Group is in growth mode," said Paul Murphy, CEO. "It's a testament to the popularity of the Einstein Bros. experience when one facility, like Johnson City Medical Center, decides to add a second restaurant on the same campus."

About Einstein Noah Restaurant Group

Einstein Noah Restaurant Group, Inc. is a leading company in the quick casual restaurant industry that operates locations primarily under the Einstein Bros. and Noah's New York Bagels brands and primarily franchises locations under the Manhattan Bagel brand. The company's retail system consists of approximately 600 restaurants, including more than 100 license locations, in 36 states and the District of Columbia. It also operates a dough production facility. The company's stock is traded under the symbol BAGL. Visit http://www.einsteinnoah.com for additional information.

Contact: Peter Jakel, (303) 568-8113 or pjakel@einsteinnoah.com


'/>"/>
SOURCE Einstein Noah Restaurant Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
2. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
7. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
8. Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals
9. Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions
10. UAN Mourns Passing of President Cheryl L. Johnson, RN
11. Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Silicon Valley Hair Institute, the San Francisco Bay Area leader ... women’s hair loss. Although hair transplant procedures can be seen as more of a ... can be two reasons a woman may see her hair thinning. , “We are ...
(Date:3/28/2017)... ... March 28, 2017 , ... “A Prophets Bones”: a thrilling adventure that reveals the ... , “There were things that his parents and teachers had asked of him that he ... he was going to defy the Almighty Creator. There were some who would have felt ...
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. Bruce Trimble ... without requiring a referral. Trimble Dental offers a variety of services to ... dental implants. Whether patients have discolored, crooked or missing teeth in Eau Claire, ...
(Date:3/27/2017)... ... March 27, 2017 , ... This is the second major ... in 2014. It is the culmination of collaborative efforts by members of ... OSEHRA Organizational Member Zato Health co-funded the ONC certification and provided key technical ...
(Date:3/27/2017)... Boston, MA (PRWEB) , ... March 27, 2017 ... ... NEJM Group, the organization behind the New England Journal of Medicine and NEJM ... , NEJM Knowledge+ Pediatrics Board Review was created by a panel of pediatricians ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017  BERG, a biopharmaceutical company uncovering ... approach, today announced that the company,s Interrogative ... new data using a cold-induced model to ... Joslin Diabetes Center led the investigation with ... analysis of samples.  The findings were published ...
(Date:3/27/2017)... NEW YORK , March 27, 2017 ... mixed colors as the NASDAQ Composite closed the trading ... 0.29% lower; and the S&P 500 was down 0.08%. ... of nine sectors finishing the day in green. Pre-market ... stocks: Wright Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: